FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084865690> ?p ?o ?g. }

• W2084865690 endingPage "11" @default.
• W2084865690 startingPage "1" @default.
• W2084865690 abstract "The purpose of this paper is to evaluate new predictive assays and their potential to modulate treatment response. Their impact is presented in the context of three EORTC clinical trials in head and neck, lung and breast cancer, showing an improvement in survival by accelerated fractionation, concomitant use of cisplatin and radiotherapy and adjuvant hormonal treatment, respectively. Assays have been developed to predict the response to treatment by measuring tumor characteristics, such as the growth potential by the labeling index after i.v. injection of IdUrd, the extent of radiation-induced stable and unstable chromosome aberrations and the induction of apoptosis. These assays could guide us in the adaptation of the individual radiation doses and fractionation schedules. The measurement of the effect of cisplatin on DNA has become feasible with the development of antibodies against DNA adducts. In a recently completed phase II dose escalation trial with concomitant radiotherapy and daily cisplatin in lung cancer, we found that patients with high DNA adduct levels measured in the buccal mucosa, had a much better survival rate than patients with a low or undetectable amount of cisplatin DNA adducts. A better understanding of the signal transduction pathways involved in radiation-induced apoptosis may help to design studies aimed at modulating the apoptotic response. We and others have recently shown that alkylphospholipids, which inhibit mitogenic signaling, induce apoptosis in a variety of tumor cell lines. In combination with ionizing radiation, these compounds cause an enhancement of apoptotic cell kill. This type of signaling-based intervention study may form the basis for new therapeutic strategies. Pretreatment levels of apoptosis may be helpful in predicting treatment outcome, although the data so far show inconsistent results. The importance of evaluating other tumor-biological parameters, including cell kinetics should be stressed. Based on assays predicting reliably the response to hormonal therapy, a more appropriate choice can be made for therapeutic intervention with hormonal therapy and for selecting the appropriate adjuvant therapy in breast cancer patients. The development of a functional estrogen receptor assay (ER-FASAY), based on a yeast growth-assay, provides a way of estimating abnormal function of the receptor in tumors with a positive estrogen receptor score as measured by a classical immuno-histochemistry assay. This yeast assay can also detect different DNA mutations of the estrogen receptor existing in an individual tumor specimen." @default.
• W2084865690 created "2016-06-24" @default.
• W2084865690 creator A5005206606 @default.
• W2084865690 creator A5013879633 @default.
• W2084865690 creator A5025640018 @default.
• W2084865690 creator A5043431861 @default.
• W2084865690 creator A5044517920 @default.
• W2084865690 creator A5054978724 @default.
• W2084865690 creator A5068893119 @default.
• W2084865690 date "1999-01-01" @default.
• W2084865690 modified "2023-10-17" @default.
• W2084865690 title "Towards prediction and modulation of treatment response" @default.
• W2084865690 cites W1562190372 @default.
• W2084865690 cites W1566441785 @default.
• W2084865690 cites W1941013643 @default.
• W2084865690 cites W1969158591 @default.
• W2084865690 cites W1971869045 @default.
• W2084865690 cites W1980172432 @default.
• W2084865690 cites W1980334365 @default.
• W2084865690 cites W1989340328 @default.
• W2084865690 cites W1993337480 @default.
• W2084865690 cites W1998841085 @default.
• W2084865690 cites W2003422693 @default.
• W2084865690 cites W2004704816 @default.
• W2084865690 cites W2014664200 @default.
• W2084865690 cites W2026055653 @default.
• W2084865690 cites W2026788229 @default.
• W2084865690 cites W2032449873 @default.
• W2084865690 cites W2036034384 @default.
• W2084865690 cites W2037957024 @default.
• W2084865690 cites W2044217649 @default.
• W2084865690 cites W2049108649 @default.
• W2084865690 cites W2050523861 @default.
• W2084865690 cites W2051455084 @default.
• W2084865690 cites W2064439294 @default.
• W2084865690 cites W2070423387 @default.
• W2084865690 cites W2074169536 @default.
• W2084865690 cites W2085409346 @default.
• W2084865690 cites W2087649879 @default.
• W2084865690 cites W2090896110 @default.
• W2084865690 cites W2094405661 @default.
• W2084865690 cites W2098663367 @default.
• W2084865690 cites W2105737184 @default.
• W2084865690 cites W2118385360 @default.
• W2084865690 cites W2123311454 @default.
• W2084865690 cites W2124353451 @default.
• W2084865690 cites W2129686798 @default.
• W2084865690 cites W2133555954 @default.
• W2084865690 cites W2135687585 @default.
• W2084865690 cites W2158053848 @default.
• W2084865690 cites W2166009803 @default.
• W2084865690 cites W2167984282 @default.
• W2084865690 cites W2312703485 @default.
• W2084865690 cites W4299315002 @default.
• W2084865690 doi "https://doi.org/10.1016/s0167-8140(99)00009-2" @default.
• W2084865690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10225551" @default.
• W2084865690 hasPublicationYear "1999" @default.
• W2084865690 type Work @default.
• W2084865690 sameAs 2084865690 @default.
• W2084865690 citedByCount "28" @default.
• W2084865690 countsByYear W20848656902012 @default.
• W2084865690 countsByYear W20848656902013 @default.
• W2084865690 countsByYear W20848656902016 @default.
• W2084865690 countsByYear W20848656902017 @default.
• W2084865690 countsByYear W20848656902019 @default.
• W2084865690 countsByYear W20848656902020 @default.
• W2084865690 countsByYear W20848656902022 @default.
• W2084865690 crossrefType "journal-article" @default.
• W2084865690 hasAuthorship W2084865690A5005206606 @default.
• W2084865690 hasAuthorship W2084865690A5013879633 @default.
• W2084865690 hasAuthorship W2084865690A5025640018 @default.
• W2084865690 hasAuthorship W2084865690A5043431861 @default.
• W2084865690 hasAuthorship W2084865690A5044517920 @default.
• W2084865690 hasAuthorship W2084865690A5054978724 @default.
• W2084865690 hasAuthorship W2084865690A5068893119 @default.
• W2084865690 hasConcept C126322002 @default.
• W2084865690 hasConcept C143425029 @default.
• W2084865690 hasConcept C143998085 @default.
• W2084865690 hasConcept C151730666 @default.
• W2084865690 hasConcept C185592680 @default.
• W2084865690 hasConcept C190283241 @default.
• W2084865690 hasConcept C2776256026 @default.
• W2084865690 hasConcept C2776530083 @default.
• W2084865690 hasConcept C2776694085 @default.
• W2084865690 hasConcept C2778239845 @default.
• W2084865690 hasConcept C2779343474 @default.
• W2084865690 hasConcept C2779384505 @default.
• W2084865690 hasConcept C502942594 @default.
• W2084865690 hasConcept C509974204 @default.
• W2084865690 hasConcept C552990157 @default.
• W2084865690 hasConcept C55493867 @default.
• W2084865690 hasConcept C62478195 @default.
• W2084865690 hasConcept C71924100 @default.
• W2084865690 hasConcept C86803240 @default.
• W2084865690 hasConcept C95444343 @default.
• W2084865690 hasConcept C98274493 @default.
• W2084865690 hasConceptScore W2084865690C126322002 @default.
• W2084865690 hasConceptScore W2084865690C143425029 @default.

• next